Systematic reviews and lifelong diseases

被引：22

作者：

Elphick, HE

Tan, A

Ashby, D

Smyth, RL ^{[1
]}

机构：

[1] Univ Liverpool, Inst Child Hlth, Alder Hey Childrens Hosp, Liverpool L12 2AP, Merseyside, England

[2] Univ London, Barts & London Queen Marys Sch Med & Dent, Wolfson Inst Prevent Med, London EC1M 6B9, England

来源：

BMJ-BRITISH MEDICAL JOURNAL | 2002年 / 325卷 / 7360期

关键词：

D O I：

10.1136/bmj.325.7360.381

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Systematic reviews of randomised controlled trials provide an evidence base for treatment but too often fail to give adequate information on long term outcomes. Elphick and colleagues discuss the limitations of the systematic review of randomised controlled trials for patients with chronic or lifelong diseases and suggest that long term observational studies have a place in the evaluation of the benefits and risks of treatment.

引用

页码：381 / 384

页数：4

共 24 条

[1]

Akbar A, 1999, ACTA PAEDIATR, V88, P783

[2]

Black N, 1996, BRIT MED J, V312, P1215

[3] Spread of beta-lactam-resistant Pseudomonas aeruginosa in a cystic fibrosis clinic [J].

Cheng, K ;

Smyth, RL ;

Govan, JRW ;

Doherty, C ;

Winstanley, C ;

Denning, N ;

Heaf, DP ;

vanSaene, H ;

Hart, CA .

LANCET, 1996, 348 (9028) :639-642

[4]

Cheng K, 2000, PEDIATR PULM, V29, P1

[5]

ELPHICK HE, 2001, COCHRANE LIB

[6] Assessment of therapeutic safety in systematic reviews: literature review [J].

Ernst, E ;

Pittler, MH .

BRITISH MEDICAL JOURNAL, 2001, 323 (7312) :546-546

[7]

Frederiksen B, 1996, PEDIATR PULM, V21, P153, DOI 10.1002/(SICI)1099-0496(199603)21:3<153::AID-PPUL1>3.0.CO

[8]

2-R

[9] INVESTIGATION OF AMINOGLYCOSIDE NEPHROTOXICITY IN CYSTIC-FIBROSIS PATIENTS [J].

GODSON, C ;

RYAN, MP ;

OHALLORAN, D ;

BOURKE, S ;

BRADY, HR ;

FITZGERALD, MX .

SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 1988, 23 :70-73

[10]

GOTSCHE PC, 2001, COCHRANE LIB

← 1 2 3 →